These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle. Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050 [TBL] [Abstract][Full Text] [Related]
4. ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation. de Toledo FG; Cheng J; Liang M; Chini EN; Dousa TP Circ Res; 2000 Jun; 86(11):1153-9. PubMed ID: 10850967 [TBL] [Abstract][Full Text] [Related]
5. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Kitanaka A; Ito C; Nishigaki H; Campana D Blood; 1996 Jul; 88(2):590-8. PubMed ID: 8695807 [TBL] [Abstract][Full Text] [Related]
6. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. Kontani K; Nishina H; Ohoka Y; Takahashi K; Katada T J Biol Chem; 1993 Aug; 268(23):16895-8. PubMed ID: 8394323 [TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation. Prus E; Fibach E Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347 [TBL] [Abstract][Full Text] [Related]
8. CD38 stimulation lowers the activation threshold and enhances the alloreactivity of cord blood T cells by activating the phosphatidylinositol 3-kinase pathway and inducing CD73 expression. Borrione P; Peola S; Mariani S; Besostri B; Mallone R; Malavasi F; Pileri A; Massaia M J Immunol; 1999 May; 162(10):6238-46. PubMed ID: 10229870 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells. Kontani K; Kukimoto I; Nishina H; Hoshino S; Hazeki O; Kanaho Y; Katada T J Biol Chem; 1996 Jan; 271(3):1534-7. PubMed ID: 8576149 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity. Congleton J; Shen M; MacDonald R; Malavasi F; Yen A Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085 [TBL] [Abstract][Full Text] [Related]
11. Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity. Nishina H; Inageda K; Takahashi K; Hoshino S; Ikeda K; Katada T Biochem Biophys Res Commun; 1994 Sep; 203(2):1318-23. PubMed ID: 8093047 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity. Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705 [TBL] [Abstract][Full Text] [Related]
13. Complex gangliosides as cell surface inhibitors for the ecto-NAD+ glycohydrolase of CD38. Hara-Yokoyama M; Nagatsuka Y; Katsumata O; Irie F; Kontani K; Hoshino S; Katada T; Ono Y; Fujita-Yoshigaki J; Sugiya H; Furuyama S; Hirabayashi Y Biochemistry; 2001 Jan; 40(4):888-95. PubMed ID: 11170409 [TBL] [Abstract][Full Text] [Related]
14. Signal transduction via the CD38/NAD+ glycohydrolase. Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684 [TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. Umar S; Malavasi F; Mehta K J Biol Chem; 1996 Jul; 271(27):15922-7. PubMed ID: 8663150 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor antagonist inhibits CD38 antigen expression on human hematopoietic cells in vitro. Prus E; Chandraratna RA; Fibach E Leuk Lymphoma; 2004 May; 45(5):1025-35. PubMed ID: 15291363 [TBL] [Abstract][Full Text] [Related]
17. Preincubation with endothelial cell monolayers increases gene transfer efficiency into human bone marrow CD34(+)CD38(-) progenitor cells. Chute JP; Saini A; Wells M; Clark W; Wu A; St Louis D; Blair P; Harlan D; Kaushal S Hum Gene Ther; 2000 Dec; 11(18):2515-28. PubMed ID: 11119422 [TBL] [Abstract][Full Text] [Related]
18. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Drach J; Zhao S; Malavasi F; Mehta K Biochem Biophys Res Commun; 1993 Sep; 195(2):545-50. PubMed ID: 7690555 [TBL] [Abstract][Full Text] [Related]
19. Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen. Inageda K; Takahashi K; Tokita K; Nishina H; Kanaho Y; Kukimoto I; Kontani K; Hoshino S; Katada T J Biochem; 1995 Jan; 117(1):125-31. PubMed ID: 7775378 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. Kishimoto H; Hoshino S; Ohori M; Kontani K; Nishina H; Suzawa M; Kato S; Katada T J Biol Chem; 1998 Jun; 273(25):15429-34. PubMed ID: 9624127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]